PharmaNutra SpA (IT:PHN) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PharmaNutra S.p.A. has signed a distribution agreement with Sigma Lifesciences to market its SiderAL® and Ultramag® products in Canada, expanding its presence in North America. The products, which feature the patented Sucrosomial® Technology, are set to launch in the second quarter of 2025. This strategic move aims to capitalize on the significant market potential in Canada.
For further insights into IT:PHN stock, check out TipRanks’ Stock Analysis page.